Both Semaglutide and Tirzepatide are GLP-1 medications studied for their effects on appetite regulation and weight management, but they work differently and are often considered for different reasons. Here's a direct comparison to help inform the conversation with your Nurse Practitioner.
| Category | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist, targets one hormone pathway | GLP-1 and GIP receptor agonist, dual-action on two hormone pathways |
| Track Record | Long-established, widely studied, extensive real-world use | Newer to market, growing body of research on the dual-pathway approach |
| Often Considered For | Those new to GLP-1 treatment, or looking for the most established option | Those who've plateaued on other approaches, or specifically interested in dual-pathway support |
| Delivery | Once-weekly injection | Once-weekly injection |
| Initiation Price | $249/mo | $299/mo |
| Titration Price | $299/mo | $429/mo |
| Maintenance Price | $349/mo | $549/mo |
This comparison is educational and general in nature. It is not medical advice and does not guarantee any specific outcome. Your prescriber will help determine which option, and which dose, is right for you based on your individual health history and goals.